Joseph Cox

Summary

Country: Canada

Publications

  1. doi Predictors of methadone program non-retention for opioid analgesic dependent patients
    Joseph Cox
    Mental Health and Addiction Services, Cape Breton District Health Authority, Sydney, Nova Scotia, Canada B1P 1P3
    J Subst Abuse Treat 44:52-60. 2013
  2. doi Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians
    J Cox
    McGill University, Montreal, QC, Canada
    J Viral Hepat 18:e332-40. 2011
  3. pmc HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada
    J Cox
    Montreal Public Health Department, Montreal, Quebec, H2L 1M3 Canada
    Sex Transm Infect 80:518-23. 2004
  4. pmc Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users
    Joseph Cox
    Direction de sante publique, Agence de la santé et des services sociaux de Montréal, Montreal, Canada
    Subst Use Misuse 44:548-68. 2009
  5. pmc Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users
    Joseph Cox
    McGill University, Montreal, Quebec, Canada
    Soc Sci Med 66:211-20. 2008
  6. ncbi Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention
    Carole Morissette
    Montreal Public Health Department, Division of Infectious Diseases, 1301 Sherbrooke Street East, Montreal, Quebec, H2L 1M3, Canada
    Int J Drug Policy 18:204-12. 2007
  7. pmc Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, 1020 Pine Avenue West, Montreal, H3A 1A2, QC, Canada
    J Urban Health 85:77-89. 2008
  8. ncbi Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    J Acquir Immune Defic Syndr 46:355-61. 2007
  9. ncbi The importance of social networks in their association to drug equipment sharing among injection drug users: a review
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    Addiction 102:1730-9. 2007
  10. pmc HIV and HCV discordant injecting partners and their association to drug equipment sharing
    Prithwish De
    Departments of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    Scand J Infect Dis 41:206-14. 2009

Collaborators

Detail Information

Publications19

  1. doi Predictors of methadone program non-retention for opioid analgesic dependent patients
    Joseph Cox
    Mental Health and Addiction Services, Cape Breton District Health Authority, Sydney, Nova Scotia, Canada B1P 1P3
    J Subst Abuse Treat 44:52-60. 2013
    ..Some determinants of involuntary discharge were modified by sex. Understanding predictors of specific loss to follow-up outcomes may help MMT programs improve patient retention...
  2. doi Knowledge, attitudes and behaviours associated with the provision of hepatitis C care by Canadian family physicians
    J Cox
    McGill University, Montreal, QC, Canada
    J Viral Hepat 18:e332-40. 2011
    ....
  3. pmc HIV status of sexual partners is more important than antiretroviral treatment related perceptions for risk taking by HIV positive MSM in Montreal, Canada
    J Cox
    Montreal Public Health Department, Montreal, Quebec, H2L 1M3 Canada
    Sex Transm Infect 80:518-23. 2004
    ..To examine the role of antiretroviral treatment related perceptions relative to other clinical and psychosocial factors associated with sexual risk taking in HIV positive men who have sex with men (MSM)...
  4. pmc Access to sterile injecting equipment is more important than awareness of HCV status for injection risk behaviors among drug users
    Joseph Cox
    Direction de sante publique, Agence de la santé et des services sociaux de Montréal, Montreal, Canada
    Subst Use Misuse 44:548-68. 2009
    ..Improved access to sterile injecting equipment may be more important than knowledge of HCV status in reducing injection risks among this IDU population. The study limitations are noted and recommendations discussed...
  5. pmc Low perceived benefits and self-efficacy are associated with hepatitis C virus (HCV) infection-related risk among injection drug users
    Joseph Cox
    McGill University, Montreal, Quebec, Canada
    Soc Sci Med 66:211-20. 2008
    ..Interventions should aim to heighten awareness of the benefits of risk reduction and provide IDUs with the skills necessary to negotiate safer injecting with their peers...
  6. ncbi Minimal uptake of sterile drug preparation equipment in a predominantly cocaine injecting population: implications for HIV and hepatitis C prevention
    Carole Morissette
    Montreal Public Health Department, Division of Infectious Diseases, 1301 Sherbrooke Street East, Montreal, Quebec, H2L 1M3, Canada
    Int J Drug Policy 18:204-12. 2007
    ..To identify factors associated with using sterile drug injection equipment by injection drug users (IDUs)...
  7. pmc Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, 1020 Pine Avenue West, Montreal, H3A 1A2, QC, Canada
    J Urban Health 85:77-89. 2008
    ..This approach can optimize the benefits of SSE while minimizing the potential risks associated with the practice of secondary exchange...
  8. ncbi Rethinking approaches to risk reduction for injection drug users: differences in drug type affect risk for HIV and hepatitis C virus infection through drug-injecting networks
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    J Acquir Immune Defic Syndr 46:355-61. 2007
    ..To identify and compare the drug-injecting network characteristics of cocaine and heroin injectors associated with a risk of HIV and hepatitis C virus (HCV)...
  9. ncbi The importance of social networks in their association to drug equipment sharing among injection drug users: a review
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, Montreal, Canada
    Addiction 102:1730-9. 2007
    ..To examine the scientific evidence regarding the association between characteristics of social networks of injection drug users (IDUs) and the sharing of drug injection equipment...
  10. pmc HIV and HCV discordant injecting partners and their association to drug equipment sharing
    Prithwish De
    Departments of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada
    Scand J Infect Dis 41:206-14. 2009
    ..The results warrant greater screening to raise awareness of infection status, post-test counselling to promote status disclosure among partners, and skill-building to avoid equipment sharing between discordant partners...
  11. ncbi Hepatitis C meanings and preventive strategies among street-involved young injection drug users in Montréal
    Elise Roy
    Service de Toxicomanie, Faculte de Medecine et des Sciences de la Sante, Universite de Sherbrooke, Longueuil, Quebec, Canada
    Int J Drug Policy 18:397-405. 2007
    ..To examine what hepatitis C virus (HCV) infection means to street-involved young IDUs (SYIDUs) and how this impacts on their health behaviours, based on social contexts in which they live...
  12. ncbi Characterizing the drug-injecting networks of cocaine and heroin injectors in Montreal
    Prithwish De
    Department of Epidemiology and Biostatistics, McGill University, Montreal, QC
    Can J Public Health 97:207-9. 2006
    ..Therefore, the objective of this study was to compare drug-injecting network characteristics of cocaine and heroin injectors believed to be associated with a risk of bloodborne infections...
  13. pmc Accuracy of physician reporting in routine public health surveillance for hepatitis C virus infection
    Klaus Jochem
    Public Health Department, Montreal Health and Social Services Agency, Montreal, Quebec, Canada
    Public Health Rep 129:64-72. 2014
    ..We evaluated physician responses to risk factor questions for non-acute HCV cases...
  14. doi Behavioural risks for HIV infection among Quebec residents of Haitian origin
    Alix Adrien
    Public Health Department, Agence de la santé et des services sociaux de Montréal, Montreal, QC, Canada
    J Immigr Minor Health 12:894-9. 2010
    ..This study allows us to identify subgroups whose behaviours can result in greater vulnerability to HIV infection and other STIs...
  15. doi Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy
    Martin Potter
    Department of Medicine, Division of Infectious Diseases, Royal Victoria Hospital, McGill University Health Centre, Montreal, Quebec, Canada
    AIDS 24:1857-65. 2010
    ..We examined the impact of spontaneous clearance of HCV on CD4(+) T-lymphocyte count progression before and after initiation of antiretroviral therapy (ART) in HIV-HCV coinfected adults...
  16. doi Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort
    Joseph Cox
    Department of Epidemiology, Biostatistics and Occupational Health, McGill University, Purvis Hall, 1020 Pine Avenue West, Montreal, Quebec, Canada H3A 1A2 Chronic Viral Illness Service, McGill University Health Centre, 3650 Saint Urbain, Montreal, Quebec, Canada H2X 2P4 Public Health Department, Montreal Health and Social Services Agency, 1301 Sherbrooke Street East, Montreal, Quebec, Canada H2L 1M3 CIHR Canadian HIV Trials Network, 588 1081 Burrard Street, Vancouver, British Columbia, Canada V6B 3E6 Electronic address
    Drug Alcohol Depend 137:121-8. 2014
    ..Ongoing drug use remains a barrier to HIV and HCV treatment. We examined the occurrence and correlates of drug use cessation among HIV-HCV co-infected drug users participating in HIV care...
  17. pmc Transmission networks of drug resistance acquired in primary/early stage HIV infection
    Bluma G Brenner
    McGill University AIDS Centre, Jewish General Hospital, Montreal, Quebec, Canada
    AIDS 22:2509-15. 2008
    ..In Quebec, half of PHIs represent clustered transmission events. This study ascertained the cumulative implications of clustering on onward transmission of drug resistance...
  18. doi HIV infection affects blood myeloid dendritic cells after successful therapy and despite nonprogressing clinical disease
    Julie Fontaine
    Laboratoire d Immunogénétique, Centre de recherche du Centre Hospitalier de l Universite de Montreal, Département de Microbiologie et Immunologie de l Université de Montréal, Montreal, Quebec, Canada
    J Infect Dis 199:1007-18. 2009
    ..pDC levels followed the pattern of CD4+ T cell fluctuations. These findings provide evidence for an ongoing process affecting mDCs after successful ART and despite nonprogressing clinical disease following HIV infection...
  19. ncbi The challenge of promoting integration: conceptualization, implementation, and assessment of a pilot care delivery model for patients with type 2 diabetes
    Louise Nasmith
    Department of Family and Community Medicine, University of Toronto, Toronto, Canada
    Fam Med 36:40-5. 2004
    ..promote behavior changes in patients to foster self-care, (3). introduce tools to allow family physicians to modify their practices, and (4). encourage local community action to support patients and providers...